Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Tirzepatide on Alcohol Intake and Reward Processing in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

NCT06939088 is registered in ClinicalTrials.gov with Anders Fink-Jensen, MD, DMSci as lead sponsor.

NCT NCT06939088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Tirzepatide on Alcohol Intake and Reward Processing in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder
Lead sponsor
Anders Fink-Jensen, MD, DMSci
Phase
Phase 2
Overall status
Recruiting
Start date
May 5, 2025
Completion date
December 31, 2028
Enrollment
108 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse/dependence, alcohol dependence, alcohol use disorder, alcoholism, schizophrenia, schizophrenia and disorders with psychotic features, schizophrenia and schizophrenia spectrum psychosis, schizophrenia disorders